Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: Developing a roadmap to improving quality care

Kidney International

Volumn 88, Issue 3, 2015, Pages 447-459

  Davison, Sara N ^a   Levin, Adeera ^b   Moss, Alvin H ^c   Jha, Vivekanand ^d,e   Brown, Edwina A ^f   Brennan, Frank ^g   Murtagh, Fliss E M ^h   Naicker, Saraladevi ⁱ   Germain, Michael J ^j   O'Donoghue, Donal J ^k   Morton, Rachael L ^l,m   Obrador, Gregorio T ⁿ  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^e GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^f HAMMERSMITH HOSPITAL   (United Kingdom)

^g ST GEORGE HOSPITAL   (Australia)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^j TUFTS UNIVERSITY   (United States)

^k SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^l UNIVERSITY OF SYDNEY   (Australia)

^m UNIVERSITY OF OXFORD   (United Kingdom)

ⁿ UNIVERSIDAD PANAMERICANA   (Mexico)

more..

Author keywords

chronic kidney disease; conservative care; palliative care; supportive care; symptoms; withdrawal of dialysis

Indexed keywords

ADVANCED CANCER; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; CONSERVATIVE TREATMENT; DECISION MAKING; DIALYSIS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HUMAN; PALLIATIVE THERAPY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; TOTAL QUALITY MANAGEMENT; TREATMENT PLANNING; TREATMENT WITHDRAWAL; CONSENSUS; COST BENEFIT ANALYSIS; ECONOMICS; NEPHROLOGY; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; STANDARDS; TREATMENT OUTCOME;

CONSENSUS; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; NEPHROLOGY; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME;

EID: 84940795994     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.110     Document Type: Conference Paper

References (178)

1. Murray AM, Arko C, Chen SC, et al. Use of hospice in the United States dialysis population. Clin J Am Soc Nephrol. 2006; 1: 1248-1255.
2. Green JA, Mor MK, Shields AM, et al. Renal provider perceptions and practice patterns regarding the management of pain, sexual dysfunction, and depression in hemodialysis patients. J Palliat Med. 2012; 15: 163-167.
3. Wong SP, Kreuter W, O'Hare AM. Treatment intensity at the end of life in older adults receiving long-Term dialysis. Arch Intern Med. 2012; 172: 661-663.
4. Davison SN. End-of-life care preferences and needs: perceptions of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010; 5: 195-204.
5. Supportive/Palliative Care in CKD: Kidney Disease Improving Global Outcomes. http://kdigo.org/home/conferences/supportivecare/ (Accessed 8 January 2015
6. WHO Definition of Palliative Care. World Health Organization. http:// www.who.int/cancer/palliative/definition/en/ (Accessed 8 January 2015
7. Dalal S, Palla S, Hui D, et al. Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. Oncologist. 2011; 16: 105-111.
8. Center to Advance Palliative Care: 2011 Public Opinion Research on Palliative Care: A Report Based on Research by Public Opinion Strategies. The Center to Advance Palliative Care: New York, 2011.
9. Wentlandt K, Krzyzanowska MK, Swami N, et al. Referral practices of oncologists to specialized palliative care. J Clin Oncol. 2012; 30: 4380-4386.
10. Morrison RS, Meier DE. Clinical practice. Palliative care. N Engl J Med. 2004; 350: 2582-2590.
11. Tamura MK, Meier DE. Five policies to promote palliative care for patients with ESRD. Clin J Am Soc Nephrol. 2013; 8: 1783-1790.
12. Davison SN, Koncicki H, Brennan F. Pain in chronic kidney disease: a scoping review. Semin Dial. 2014; 27: 188-204.
13. Davison SN, Jhangri GS, Johnson JA. Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: a simple assessment of symptom burden. Kidney Int. 2006; 69: 1621-1625.
14. Davison SN, Jhangri GS, Johnson JA. Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients. Nephrol Dial Transplant. 2006; 21: 3189-3195.
15. Davison SN Edmonton Symptom Assessment System Revised: Renal (ESAS-r: Renal). Vol. 2014, 2014.
16. Hearn J, Higginson IJ. Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. Qual Health Care. 1999; 8: 219-227.
17. Murphy EL, Murtagh FE, Carey I, et al. Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool. Nephron Clin Pract. 2009; 111: c74-c80.
18. Weisbord SD, Fried LF, Arnold RM, et al. Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index. J Pain Symptom Manage. 2004; 27: 226-240.
19. Davison SN, Jhangri GS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. J Pain Symptom Manage. 2010; 39: 477-485.
20. Kimmel PL, Emont SL, Newmann JM, et al. ESRD patient quality of life: symptoms, spiritual beliefs, psychosocial factors, and ethnicity. Am J Kidney Dis. 2003; 42: 713-721.
21. Leinau L, Murphy TE, Bradley E, et al. Relationship between conditions addressed by hemodialysis guidelines and non-ESRD-specific conditions affecting quality of life. Clin J Am Soc Nephrol. 2009; 4: 572-578.
22. Weisbord SD, Carmody SS, Bruns FJ, et al. Symptom burden, quality of life, advance care planning and the potential value of palliative care in severely ill haemodialysis patients. Nephrol Dial Transplant. 2003; 18: 1345-1352.
23. Weisbord SD, Fried LF, Arnold RM, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol. 2005; 16: 2487-2494.
24. Gamondi C, Galli N, Schonholzer C, et al. Frequency and severity of pain and symptom distress among patients with chronic kidney disease receiving dialysis. Swiss Med Wkly. 2013; 143: w13750.
25. Weisbord SD, Fried LF, Mor MK, et al. Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol. 2007; 2: 960-967.
26. O'Hare AM, Armistead N, Schrag WL, et al. Patient-centered care: an opportunity to accomplish the " Three Aims" of the National Quality Strategy in the Medicare ESRD program. Clin J Am Soc Nephrol. 2014; 9: 2189-2194.
27. Manns B, Hemmelgarn B, Lillie E, et al. Setting research priorities for patients on or nearing dialysis. Clin J Am Soc Nephrol. 2014; 9: 1813-1821.
28. Hedayati SS, Minhajuddin AT, Toto RD, et al. Validation of depression screening scales in patients with CKD. Am J Kidney Dis. 2009; 54: 433-439.
29. Craven JL, Rodin GM, Littlefield C. The Beck Depression Inventory as a screening device for major depression in renal dialysis patients. Int J Psychiatry Med. 1988; 18: 365-374.
30. Hedayati SS, Bosworth HB, Kuchibhatla M, et al. The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int. 2006; 69: 1662-1668.
31. Watnick S, Wang PL, Demadura T, et al. Validation of 2 depression screening tools in dialysis patients. Am J Kidney Dis. 2005; 46: 919-924.
32. Wachterman MW, Marcantonio ER, Davis RB, et al. Relationship between the prognostic expectations of seriously ill patients undergoing hemodialysis and their nephrologists. JAMA Intern Med. 2013; 173: 1206-1214.
33. Murtagh FE, Sheerin NS, Addington-Hall J, et al. Trajectories of illness in stage 5 chronic kidney disease: a longitudinal study of patient symptoms and concerns in the last year of life. Clin J Am Soc Nephrol. 2011; 6: 1580-1590.
34. Gill TM, Gahbauer EA, Han L, et al. Trajectories of disability in the last year of life. N Engl J Med. 2010; 362: 1173-1180.
35. Schell JO, Patel UD, Steinhauser KE, et al. Discussions of the kidney disease trajectory by elderly patients and nephrologists: a qualitative study. Am J Kidney Dis. 2012; 59: 495-503.
36. Cohen LM, Ruthazner R, Moss AH, et al. Predicting six-month mortality in patients maintained with hemodialysis. Clin J Am Soc Nephrol. 2010; 5: 72-79.
37. Couchoud C, Labeeuw M, Moranne O, et al. A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol Dial Transplant. 2009; 24: 1553-1561.
38. Moss AH, Ganjoo J, Sharma S, et al. Utility of the " surprise" question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol. 2008; 3: 1379-1384.
39. Ifudu O, Paul HR, Homel P, et al. Predictive value of functional status for mortality in patients on maintenance hemodialysis. Am J Nephrol. 1998; 18: 109-116.
40. Stewart M, Brown JB, Weston WW, et al. Patient-Centered Medicine: Transforming the Clinical Method. 2nd edn, Radcliffe Medical Press: UK, 2003.
41. Mead N, Bower P. Patient-centredness: a conceptual framework and review of the empirical literature. Soc Sci Med. 2000; 51: 1087-1110.
42. Morton RL, Tong A, Howard K, et al. The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. BMJ. 2010; 340: c112.
43. Davison SN. Facilitating advance care planning for patients with endstage renal disease: the patient perspective. Clin J Am Soc Nephrol. 2006; 1: 1023-1028.
44. Pruchno RA, Lemay EP Jr, Feild L, et al. Predictors of patient treatment preferences and spouse substituted judgments: the case of dialysis continuation. Med Decis Making. 2006; 26: 112-121.
45. Miura Y, Asai A, Matsushima M, et al. Families' and physicians' predictions of dialysis patients' preferences regarding life-sustaining treatments in Japan. Am J Kidney Dis. 2006; 47: 122-130.
46. Fine A, Fontaine B, Kraushar M, et al. Nephrologists should voluntarily divulge survival data to potential dialysis patients: a questionnaire study. Perit Dial Int. 2005; 25: 269-273.
47. Davison SN, Simpson C. Hope and advance care planning in patients with end stage renal disease: qualitative interview study. BMJ. 2006; 333: 886.
48. Davison SN, Torgunrud C. The creation of an advance care planning process for patients with ESRD. Am J Kidney Dis. 2007; 49: 27-36.
49. Alberta Health Services Advance Care Planning. http://www. albertahealthservices.ca/9098.asp. (Accessed 8 January 2015
50. Respecting Choices. Advance Care Planning. http://respectingchoices. org/ (Accessed 8 January 2015
51. Schell JO, Green JA, Tulsky JA, et al. Communication skills training for dialysis decision-making and end-of-life care in nephrology. Clin J Am Soc Nephrol. 2013; 8: 675-680.
52. Schell JO, Arnold RM. NephroTalk: communication tools to enhance patient-centered care. Semin Dial. 2012; 25: 611-616.
53. Brinkman-Stoppelenburg A, Rietjens JA, van der Heide A. The effects of advance care planning on end-of-life care: a systematic review. Palliat Med. 2014; 28: 1000-1025.
54. Detering KM, Hancock AD, Reade MC, et al. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ. 2010; 340: c1345.
55. Kirchhoff KT, Hammes BJ, Kehl KA, et al. Impact of a disease-specific planning intervention on surrogate understanding of patient goals for future medical treatment. J Am Geriatr Soc. 2010; 58: 1233-1240.
56. Murphy E, Germain MJ, Cairns H, et al. International variation in classification of dialysis withdrawal: a systematic review. Nephrol Dial Transplant. 2014; 29: 625-635.
57. Renal Physicians Association. Shared Decision-Making in the Appropriate Initiation of and Withdrawal from Dialysis (Clinical Practice Guideline). 2nd edn. Rockville, Maryland, 2010.
58. Lambie M, Rayner HC, Bragg-Gresham JL, et al. Starting and withdrawing haemodialysis-Associations between nephrologists' opinions, patient characteristics and practice patterns (data from the Dialysis Outcomes and Practice Patterns Study). Nephrol Dial Transplant. 2006; 21: 2814-2820.
59. Seah AS, Tan F, Srinivas S, et al. Opting out of dialysis - Exploring patients' decisions to forego dialysis in favour of conservative non-dialytic management for end-stage renal disease. Health Expect 2013. (doi:10.111/hex.12075
60. Burns A, Carson RC. maximum conservative management: a worthwhile treatment for elderly patients with renal failure who choose not to undergo dialysis. J Palliat Med. 2007; 10: 1245-1247.
61. Noble H, Kelly D, Rawlings-Anderson K, et al. A concept analysis of renal supportive care: the changing world of nephrology. J Adv Nurs. 2007; 59: 644-653.
62. Morton RL, Snelling P, Webster AC, et al. Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ. 2012; 184: E277-E283.
63. Reubi F. [Conservative therapy of chronic renal failure]. Helv Med Acta Suppl. 1969; 49: 88-99.
64. Moncrief JW, Decherd JF. Conservative management of end-stage renal failure. Texas Med. 1975; 71: 74-79.
65. Burns A. Conservative management of end-stage renal failure: masterly inactivity or benign neglect?. Nephron Clin Pract. 2003; 95: c37-c39.
66. Murtagh FEM, Spagnolo AG, Panocchia N, et al. Conservative (non dialytic) management of end-stage renal disease and withdrawal of dialysis. Prog Palliat Care. 2009; 17: 179-185.
67. Murtagh FE, Marsh JE, Donohoe P, et al. Dialysis or not?. A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant. 2007; 22: 1955-1962.
68. Chandna SM, Da Silva-Gane M, Marshall C, et al. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant. 2011; 26: 1608-1614.
69. Hussain JA, Mooney A, Russon L. Comparison of survival analysis and palliative care involvement in patients aged over 70 years choosing conservative management or renal replacement therapy in advanced chronic kidney disease. Palliat Med. 2013; 27: 829-839.
70. Carson RC, Juszczak M, Davenport A, et al. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease?. Clin J Am Soc Nephrol. 2009; 4: 1611-1619.
71. Davison SN, Jhangri GS, Holley JL, et al. Nephrologists' reported preparedness for end-of-life decision-making. Clin J Am Soc Nephrol. 2006; 1: 1256-1262.
72. Holley JL, Davison SN, Moss AH. Nephrologists' changing practices in reported end-of-life decision-making. Clin J Am Soc Nephrol. 2007; 2: 107-111.
73. Shah HH, Monga D, Caperna A, et al. Palliative care experience of US adult nephrology fellows: a national survey. Ren Fail. 2014; 36: 39-45.
74. Holley JL, Carmody SS, Moss AH, et al. The need for end-of-life care training in nephrology: national survey results of nephrology fellows. Am J Kidney Dis. 2003; 42: 813-820.
75. Combs SA, Culp S, Matlock DD, et al. Update on end-of-life care training during nephrology fellowship: a cross-sectional national survey of fellows. Am J Kidney Dis. 2014; 65: 233-239.
76. Quill TE, Abernethy AP. Generalist plus specialist palliative care-creating a more sustainable model. N Engl J Med. 2013; 368: 1173-1175.
77. Smith S, Brick A, O'Hara S, et al. Evidence on the cost and costeffectiveness of palliative care: a literature review. Palliat Med. 2014; 28: 130-150.
78. Lee CP, Chertow GM, Zenios SA. An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard. Value Health. 2009; 12: 80-87.
79. Welter Ede Q, Frainer RH, Maldotti A, et al. Evaluating the association between alterations in mineral metabolism and pruritus in hemodialysis patients. An Bras Dermatol. 2011; 86: 31-36.
80. Tessari G, Dalle Vedove C, Loschiavo C, et al. The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study. J Nephrol. 2009; 22: 241-248.
81. Szepietowski JC, Sikora M, Kusztal M, et al. Uremic pruritus: a clinical study of maintenance hemodialysis patients. J Dermatol. 2002; 29: 621-627.
82. Stahle-Backdahl M, Hagermark O, Lins LE. Pruritus in patients on maintenance hemodialysis. Acta Med Scand. 1988; 224: 55-60.
83. Razeghi E, Tavakolizadeh S, Ahmadi F. Inflammation and pruritus in hemodialysis patients. Saudi J Kidney Dis Transpl. 2008; 19: 62-66.
84. Mistik S, Utas S, Ferahbas A, et al. An epidemiology study of patients with uremic pruritus. J Eur Acad Dermatol Venereol. 2006; 20: 672-678.
85. Merkus MP, Jager KJ, Dekker FW, et al. Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD). Nephrol Dial Transplant. 1999; 14: 1163-1170.
86. Mathur VS, Lindberg J, Germain M, et al. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol. 2010; 5: 1410-1419.
87. Lopes GB, Nogueira FC, de Souza MR, et al. Assessment of the psychological burden associated with pruritus in hemodialysis patients using the kidney disease quality of life short form. Qual Life Res. 2012; 21: 603-612.
88. Kosmadakis G, Papakonstantinou S, Theodoros C, et al. Characteristics of uremic pruritus in hemodialysis patients: data from a single center. Kidney Int. 2008; 74: 962-963.
89. Gilchrest BA, Stern RS, Steinman TI, et al. Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol. 1982; 118: 154-156.
90. Chiu YL, Chen HY, Chuang YF, et al. Association of uraemic pruritus with inflammation and hepatitis infection in haemodialysis patients. Nephrol Dial Transplant. 2008; 23: 3685-3689.
91. Altmeyer P, Kachel HG, Junger M, et al. [Skin changes in long-Term dialysis patients. clinical study]. Hautarzt. 1982; 33: 303-309.
92. Balaskas EV, Uldall RP. Erythropoietin treatment does not improve uremic pruritus. Perit Dial Int. 1992; 12: 330-331.
93. Bencini PL, Montagnino G, Citterio A, et al. Cutaneous abnormalities in uremic patients. Nephron. 1985; 40: 316-321.
94. Duque MI, Thevarajah S, Chan YH, et al. Uremic pruritus is associated with higher kt/V and serum calcium concentration. Clin Nephrol. 2006; 66: 184-191.
95. Matsumoto M, Ichimaru K, Horie A. Pruritus and mast cell proliferation of the skin in end stage renal failure. Clin Nephrol. 1985; 23: 285-288.
96. Melo NC, Elias RM, Castro MC, et al. Pruritus in hemodialysis patients: the problem remains. Hemodial Int. 2009; 13: 38-42.
97. Mettang T, Fritz P, Weber J, et al. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol. 1990; 34: 136-141.
98. Narita I, Alchi B, Omori K, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int. 2006; 69: 1626-1632.
99. Pauli-Magnus C, Mikus G, Alscher DM, et al. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebocontrolled crossover study. J Am Soc Nephrol. 2000; 11: 514-519.
100. Young AW Jr, Sweeney EW, David DS, et al. Dermatologic evaluation of pruritus in patients on hemodialysis. NY State J Med. 1973; 73: 2670-2674.
101. Zucker I, Yosipovitch G, David M, et al. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol. 2003; 49: 842-846.
102. Pisoni RL, Wikstrom B, Elder SJ, et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006; 21: 3495-3505.
103. Yamamoto Y, Hayashino Y, Akiba T, et al. Depressive symptoms predict the subsequent risk of bodily pain in dialysis patients: Japan Dialysis Outcomes and Practice Patterns Study. Pain Med. 2009; 10: 883-889.
104. de Barbieri I, Zampieron A. A descriptive analysis of sleep disturbances in patients with end-stage renal disease undergoing haemodialysis. EDTNA ERCA J. 2004; 30: 213-216.
105. De Santo RM, Bartiromo M, Cesare CM, et al. Sleep disorders occur very early in chronic kidney disease. J Nephrol. 2008; 21: S59-S65.
106. De Vecchi A, Finazzi S, Padalino R, et al. Sleep disorders in peritoneal and haemodialysis patients as assessed by a self-Administered questionnaire. Int J Artif Organs. 2000; 23: 237-242.
107. Guney I, Solak Y, Atalay H, et al. Comparison of effects of automated peritoneal dialysis and continuous ambulatory peritoneal dialysis on health-related quality of life, sleep quality, and depression. Hemodial Int. 2010; 14: 515-522.
108. Holley JL, Nespor S, Rault R. Characterizing sleep disorders in chronic hemodialysis patients. ASAIO Trans. 1991; 37: M456-M457.
109. Holley JL, Nespor S, Rault R. A comparison of reported sleep disorders in patients on chronic hemodialysis and continuous peritoneal dialysis. Am J Kidney Dis. 1992; 19: 156-161.
110. Ibrahim JM, Wegdan OM. Epidemiology of sleep disorders in patients with chronic renal disease in Cairo, Egypt. J Egypt Public Health Assoc. 2011; 86: 68-72.
111. Kurella M, Luan J, Lash JP, et al. Self-Assessed sleep quality in chronic kidney disease. Int Urol Nephrol. 2005; 37: 159-165.
112. Lui SL, Ng F, Lo WK. Factors associated with sleep disorders in Chinese patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2002; 22: 677-682.
113. Sabry AA, Abo-Zenah H, Wafa E, et al. Sleep disorders in hemodialysis patients. Saudi J Kidney Dis Transplant. 2010; 21: 300-305.
114. Walker S, Fine A, Kryger MH. Sleep complaints are common in a dialysis unit. Am J Kidney Dis. 1995; 26: 751-756.
115. Kalousova M, Tesar V, Sonka K, et al. [Sleep disorders in hemodialysis patients]. Cas Lek Cesk. 2001; 140: 500-502.
116. Kalousova M, Tesar V, Sonka K, et al. [Sleep disorders in patients treated with continuous ambulatory peritoneal dialysis]. Sb Lek. 2001; 102: 395-400.
117. Yngman-Uhlin P, Edell-Gustafsson U. Self-reported subjective sleep quality and fatigue in patients with peritoneal dialysis treatment at home. Int J Nurs Pract. 2006; 12: 143-152.
118. Araujo SM, Bruin VM, Daher EF, et al. Quality of sleep and day-Time sleepiness in chronic hemodialysis: a study of 400 patients. Scand J Urol Nephrol. 2011; 45: 359-364.
119. Brekke FB, Amro A, Hortemo Osthus TB, et al. Sleep complaints, depression and quality of life in Norwegian dialysis patients. Clin Nephrol. 2013; 80: 88-97.
120. Cengic B, Resic H, Spasovski G, et al. Quality of sleep in patients undergoing hemodialysis. Int Urol Nephrol. 2012; 44: 557-567.
121. Eryavuz N, Yuksel S, Acarturk G, et al. Comparison of sleep quality between hemodialysis and peritoneal dialysis patients. Int Urol Nephrol. 2008; 40: 785-791.
122. Guney I, Biyik M, Yeksan M, et al. Sleep quality and depression in peritoneal dialysis patients. Ren Fail. 2008; 30: 1017-1022.
123. Harris TJ, Nazir R, Khetpal P, et al. Pain, sleep disturbance and survival in hemodialysis patients. Nephrol Dial Transplant. 2012; 27: 758-765.
124. Iliescu EA, Coo H, McMurray MH, et al. Quality of sleep and health-related quality of life in haemodialysis patients. Nephrol Dial Transplant. 2003; 18: 126-132.
125. Joshwa B, Khakha DC, Mahajan S. Fatigue and depression and sleep problems among hemodialysis patients in a tertiary care center. Saudi J Kidney Dis Transplant. 2012; 23: 729-735.
126. Kusleikaite N, Bumblyte IA, Razukeviciene L, et al. [Sleep disorders and quality of life in patients on hemodialysis]. Medicina (Kaunas) 2005; 41 (Suppl 1): 69-74.
127. Pai MF, Hsu SP, Yang SY, et al. Sleep disturbance in chronic hemodialysis patients: the impact of depression and anemia. Ren Fail. 2007; 29: 673-677.
128. Sabbagh R, Iqbal S, Vasilevsky M, et al. Correlation between physical functioning and sleep disturbances in hemodialysis patients. Hemodial Int. 2008; 12(Suppl 2): S20-S24.
129. Chiu YL, Chuang YF, Fang KC, et al. Higher systemic inflammation is associated with poorer sleep quality in stable haemodialysis patients. Nephrol Dial Transplant. 2009; 24: 247-251.
130. Edalat-Nejad M, Qlich-Khani M. Quality of life and sleep in hemodialysis patients. Saudi J Kidney Dis Transplant. 2013; 24: 514-518.
131. Li J, Guo Q, Ye X, et al. Prevalence and risk factors of sleep disturbance in continuous ambulatory peritoneal dialysis patients in Guangzhou, southern China. Int Urol Nephrol. 2012; 44: 929-936.
132. Yang JY, Huang JW, Chiang CK, et al. Higher plasma interleukin-18 levels associated with poor quality of sleep in peritoneal dialysis patients. Nephrol Dial Transplant. 2007; 22: 3606-3609.
133. Bastos JP, Sousa RB, Nepomuceno LA, et al. Sleep disturbances in patients on maintenance hemodialysis: role of dialysis shift. Rev Assoc Med Bras. 2007; 53: 492-496.
134. Chen WC, Lim PS, Wu WC, et al. Sleep behavior disorders in a large cohort of chinese (Taiwanese) patients maintained by long-Term hemodialysis. Am J Kidney Dis. 2006; 48: 277-284.
135. Han SY, Yoon JW, Jo SK, et al. Insomnia in diabetic hemodialysis patients. Prevalence and risk factors by a multicenter study. Nephron. 2002; 92: 127-132.
136. Hsu CY, Lee CT, Lee YJ, et al. Better sleep quality and less daytime symptoms in patients on evening hemodialysis: a questionnairebased study. Artif Organs. 2008; 32: 711-716.
137. Hui DS, Wong TY, Ko FW, et al. Prevalence of sleep disturbances in chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 2000; 36: 783-788.
138. Jurado-Gamez B, Martin-Malo A, Alvarez-Lara MA, et al. Sleep disorders are underdiagnosed in patients on maintenance hemodialysis. Nephron Clin Pract. 2007; 105: c35-c42.
139. Malaki M, Mortazavi FS, Moazemi S, et al. Insomnia and limb pain in hemodialysis patients: what is the share of restless leg syndrome?. Saudi J Kidney Dis Transplant. 2012; 23: 15-20.
140. Merlino G, Piani A, Dolso P, et al. Sleep disorders in patients with endstage renal disease undergoing dialysis therapy. Nephrol Dial Transplant. 2006; 21: 184-190.
141. Noda A, Nakai S, Soga T, et al. Factors contributing to sleep disturbance and hypnotic drug use in hemodialysis patients. Intern Med. 2006; 45: 1273-1278.
142. Sabbatini M, Minale B, Crispo A, et al. Insomnia in maintenance haemodialysis patients. Nephrol Dial Transplant. 2002; 17: 852-856.
143. Stepanski E, Faber M, Zorick F, et al. Sleep disorders in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 1995; 6: 192-197.
144. Cantekin I, Tan M. Determination of sleep quality and fatigue level of patients receiving continuous ambulatory peritoneal dialysis in Turkey. Scand J Urol Nephrol. 2011; 45: 452-460.
145. Rodrigue JR, Mandelbrot DA, Hanto DW, et al. A cross-sectional study of fatigue and sleep quality before and after kidney transplantation. Clin Transplant. 2011; 25: E13-E21.
146. Erdogan A, Dervisoglu E, Kutlu A. Sleep quality and its correlates in patients on continuous ambulatory peritoneal dialysis. Scand J Urol Nephrol. 2012; 46: 441-447.
147. Iliescu EA, Yeates KE, Holland DC. Quality of sleep in patients with chronic kidney disease. Nephrol Dial Transplant. 2004; 19: 95-99.
148. Elder SJ, Pisoni RL, Akizawa T, et al. Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2008; 23: 998-1004.
149. Yang JY, Huang JW, Peng YS, et al. Quality of sleep and psychosocial factors for patients undergoing peritoneal dialysis. Perit Dial Int. 2007; 27: 675-680.
150. Theofilou P. Association of insomnia symptoms with kidney disease quality of life reported by patients on maintenance dialysis. Psychol Health Med. 2013; 18: 70-78.
151. Liakopoulos V, Sakkas GK, Giannaki CD, et al. Factors affecting quality of sleep in dialysis patients: preliminary polysomnographic evidence. Ren Fail. 2008; 30: 475-476.
152. Novak M, Mendelssohn D, Shapiro CM, et al. Diagnosis and management of sleep apnea syndrome and restless legs syndrome in dialysis patients. Semin Dial. 2006; 19: 210-216.
153. Mucsi I, Molnar MZ, Ambrus C, et al. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant. 2005; 20: 571-577.
154. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in endstage renal disease. Am J Kidney Dis. 1996; 28: 372-378.
155. La Manna G, Pizza F, Persici E, et al. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-Term haemodialysis treatment. Nephrol Dial Transplant. 2011; 26: 1976-1983.
156. Giannaki CD, Sakkas GK, Karatzaferi C, et al. Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a sixmonth randomized, partially double-blind, placebo-controlled comparative study. BMC Nephrol. 2013; 14: 194.
157. Giannaki CD, Hadjigeorgiou GM, Karatzaferi C, et al. A single-blind randomized controlled trial to evaluate the effect of 6 months of progressive aerobic exercise training in patients with uraemic restless legs syndrome. Nephrol Dial Transplant. 2013; 28: 2834-2840.
158. Sakkas GK, Hadjigeorgiou GM, Karatzaferi C, et al. Intradialytic aerobic exercise training ameliorates symptoms of restless legs syndrome and improves functional capacity in patients on hemodialysis: a pilot study. ASAIO J. 2008; 54: 185-190.
159. Eliasson AH, Lettieri CJ. Sequential compression devices for treatment of restless legs syndrome. Medicine (Baltimore) 2007; 86: 317-323.
160. Lettieri CJ, Eliasson AH. Pneumatic compression devices are an effective therapy for restless legs syndrome: a prospective, randomized, doubleblinded, sham-controlled trial. Chest. 2009; 135: 74-80.
161. Rajaram SS, Shanahan J, Ash C, et al. Enhanced external counter pulsation (EECP) as a novel treatment for restless legs syndrome (RLS): a preliminary test of the vascular neurologic hypothesis for RLS. Sleep Med. 2005; 6: 101-106.
162. Kalantar-Zadeh K, Block G, McAllister CJ, et al. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr. 2004; 80: 299-307.
163. Gama-Axelsson T, Lindholm B, Barany P, et al. Self-rated appetite as a predictor of mortality in patients with stage 5 chronic kidney disease. J Ren Nutr. 2013; 23: 106-113.
164. Bossola M, Ciciarelli C, Di Stasio E, et al. Relationship between appetite and symptoms of depression and anxiety in patients on chronic hemodialysis. J Ren Nutr. 2012; 22: 27-33.
165. Palmer S, Vecchio M, Craig JC, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-Analysis of observational studies. Kidney Int. 2013; 84: 179-191.
166. Hedayati SS, Grambow SC, Szczech LA, et al. Physician-diagnosed depression as a correlate of hospitalizations in patients receiving longterm hemodialysis. Am J Kidney Dis. 2005; 46: 642-649.
167. Lopes AA, Albert JM, Young EW, et al. Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int. 2004; 66: 2047-2053.
168. Palmer SC, Vecchio M, Craig JC, et al. Association between depression and death in people with CKD: a meta-Analysis of cohort studies. Am J Kidney Dis. 2013; 62: 493-505.
169. Fischer MJ, Xie D, Jordan N, et al. Factors associated with depressive symptoms and use of antidepressant medications among participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Studies. Am J Kidney Dis. 2012; 60: 27-38.
170. Nagler EV, Webster AC, Vanholder R, et al. Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2012; 27: 3736-3745.
171. Jaber BL, Lee Y, Collins AJ, et al. Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis. 2010; 56: 531-539.
172. Chertow GM, Levin NW, Beck GJ, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010; 363: 2287-2300.
173. Cukor D, Ver Halen N, Asher DR, et al. Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis. J Am Soc Nephrol. 2014; 25: 196-206.
174. Duarte PS, Miyazaki MC, Blay SL, et al. Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney Int. 2009; 76: 414-421.
175. Levendoglu F, Altintepe L, Okudan N, et al. A twelve week exercise program improves the psychological status, quality of life and work capacity in hemodialysis patients. J Nephrol. 2004; 17: 826-832.
176. Ouzouni S, Kouidi E, Sioulis A, et al. Effects of intradialytic exercise training on health-related quality of life indices in haemodialysis patients. Clin Rehabil. 2009; 23: 53-63.
177. Murtagh FE, Addington-Hall JM, Edmonds PM, et al. Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J Palliat Med. 2007; 10: 1266-1276.
178. Noble H, Meyer PJ, Bridge DJ, et al. Exploring symptoms in patients managed without dialysis: a qualitative research study. J Ren Care. 2010; 36: 9-15.